Brief: Aziyo Biologics Appoints Randy Mills Chief Executive Officer
09/08/2022 23:13
Aug 9 (Reuters) - Aziyo Biologics Inc AZYO.O :
* AZIYO BIOLOGICS CO-FOUNDER AND REGENERATIVE MEDICINE
PIONEER,
DR. RANDY MILLS, APPOINTED CHIEF EXECUTIVE OFFICER
Source text for Eikon: ID:nGNX44W1w6
Further company coverage: AZYO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Elutia
See all newsBrief: Elutia Receives $8 Million Payment From Boston Scientific Company Now Fully Funded Into 2029
Elutia Inc reports results for the quarter ended June 30 - Earnings Summary
Brief: Elutia Secures $15 Million Loan Financing From Avenue Capital Group
Elutia's Q2 revenue falls on SimpliDerm production disruption
Elutia Inc expected to post a loss of 15 cents a share - Earnings Preview